CCL5 and neoplasm: Some studies suggest that RANTES/CCL5 production may lead to a more immune-suppressive activity in tumor microenvironment (TME) [19], while other evidence suggests that RANTES/CCL5 is in favor of tumor immunity [40,41,42,43].